These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 22898311)

  • 1. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.
    Hueb W; Gersh BJ; Rezende PC; Garzillo CL; Lima EG; Vieira RD; Garcia RM; Favarato D; Segre CA; Pereira AC; Soares PR; Ribeiro E; Lemos P; Perin MA; Strunz CC; Dallan LA; Jatene FB; Stolf NA; Hueb AC; Dias R; Gaiotto FA; da Costa LM; Oikawa FT; de Melo RM; Serrano CV; de Ávila LF; Villa AV; Filho JR; Nomura C; Ramires JA; Kalil Filho R;
    BMC Cardiovasc Disord; 2012 Aug; 12():65. PubMed ID: 22898311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial injury following coronary artery surgery versus angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging.
    van Gaal WJ; Arnold JR; Testa L; Karamitsos T; Lim CC; Ponnuthurai FA; Petersen S; Francis JM; Selvanayagam J; Sayeed R; West N; Westaby S; Neubauer S; Banning AP
    EuroIntervention; 2011 Jan; 6(6):703-10. PubMed ID: 21205592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic levels of endothelin correlate with systemic inflammation and not with myocardial injury or left ventricular ejection fraction in patients undergoing percutaneous coronary intervention and on-pump coronary artery bypass grafting.
    Cuculi F; Lim CC; van Gaal W; Testa L; Westaby S; Arnold JR; Neubauer S; Banning AP
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):585-9. PubMed ID: 21908890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial.
    Hueb W; Gersh BJ; Alves da Costa LM; Costa Oikawa FT; Vieira de Melo RM; Rezende PC; Garzillo CL; Lima EG; Nomura CH; Villa AV; Hueb AC; Cassaro Strunz CM; Favarato D; Takiuti ME; de Albuquerque CP; Ribeiro da Silva EE; Franchini Ramires JA; Kalil Filho R
    Ann Thorac Surg; 2016 Jun; 101(6):2202-8. PubMed ID: 26912303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
    Vieira de Melo RM; Hueb W; Nomura CH; Ribeiro da Silva EE; Villa AV; Oikawa FTC; da Costa LMA; Rezende PC; Garzillo CL; Lima EG; Franchini Ramires JA; Kalil Filho R
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):87-93. PubMed ID: 28573785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging.
    Kirschbaum SW; Springeling T; Boersma E; Moelker A; van der Giessen WJ; Serruys PW; de Feyter PJ; van Geuns RJ
    JACC Cardiovasc Interv; 2010 Apr; 3(4):392-400. PubMed ID: 20398866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance.
    Oikawa FTC; Hueb W; Nomura CH; Hueb AC; Villa AV; da Costa LMA; de Melo RMV; Rezende PC; Segre CAW; Garzillo CL; Lima EG; Ramires JAF; Filho RK
    J Cardiothorac Surg; 2017 Dec; 12(1):122. PubMed ID: 29284532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac troponin I versus creatine kinase-MB in the detection of postoperative cardiac events after coronary artery bypass grafting surgery.
    Tzimas PG; Milionis HJ; Arnaoutoglou HM; Kalantzi KJ; Pappas K; Karfis E; Korantzopoulos P; Drossos G; Papadopoulos GS
    J Cardiovasc Surg (Torino); 2008 Feb; 49(1):95-101. PubMed ID: 18212694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery.
    Muehlschlegel JD; Perry TE; Liu KY; Fox AA; Collard CD; Shernan SK; Body SC
    Anesth Analg; 2010 Nov; 111(5):1101-9. PubMed ID: 20457766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity cardiac troponin T is more helpful in detecting peri-operative myocardial injury and apoptosis during coronary artery bypass graft surgery.
    Kocak EF; Kocak C; Aksoy A; Isiklar OO; Akcilar R; Ozdomanic IF; Unsal C; Celenk M; Altuntas I
    Cardiovasc J Afr; 2015; 26(6):234-41. PubMed ID: 26212819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of left ventricle diastolic function in myocardial infarction patients treated with primary angioplasty.
    Misztal M; Stopyra K; Gackowski A; Zmudka K; Piwowarska W
    Cardiol J; 2009; 16(5):440-6. PubMed ID: 19753523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
    Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant elevation of biomarkers of myocardial necrosis after coronary artery bypass grafting without myocardial infarction established assessed by cardiac magnetic resonance.
    da Costa LMA; Hueb W; Nomura CH; Hueb AC; Villa AV; Oikawa FTC; Vieira de Melo RM; Rezende PC; Segre CAW; Garzillo CL; Lima EG; Ramires JAF; Kalil Filho R
    Medicine (Baltimore); 2017 Feb; 96(6):e6053. PubMed ID: 28178154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
    Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
    Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.